This animal model study in rats investigated whether the peptide BPC 157 could resolve tracheocutaneous fistulas (abnormal passages between the trachea and skin) through mechanisms involving the nitric oxide (NO) system. Researchers found that BPC 157 treatment promoted fistula healing and closure, with evidence suggesting involvement of three NO-related pathways. This is an animal model study and does not represent human clinical evidence.